JasminJoMD (find me in Bluesky)

Associate professor and neuro-oncologist at University of Virginia

[UVA Neurooncology @UVA_Neuroonc]

Huge congratulations to our fellow, Dr. Sami Khan on being selected for the prestigious inaugural UVA GME Clinician Educator Track! He will join a multidisciplinary cohort of fellows and residents to advance skills in medical education, teaching, and scholarship. #UVANeurology

[Evan Noch @EvanNoch]

First new author interview for @NeuroOnc Neuro-oncology: The Podcast 2.0 by Iyad Alnahhas 🧠 https://t.co/8vKbsK6M3v

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Among a sea of amazing women at the SNO 2025 meeting in Hawaii 🌺

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Congrats to our former UVA fellow, Dr. Marky Mondia on presenting our work on the prognostic value of time-to-progression after first recurrence in IDH-mutant low grade glioma @UVANeurology #SNO2025 #UVANeurooncology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Dr. David Schiff presenting the updated molecular analysis of E3F05 showing significant survival benefit with RT and temozolomide in grade 2 IDH-mutant astrocytoma @UVANeurology #UVANeurooncology #SNO2025

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Grateful for the opportunity to present our study identifying patients with GBM with increased risk to develop early and late VTE @UVANeurology #SNO2025 #UVANeurooncology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Soaking up the aloha vibe with UVA crew and fam at SNO in Honolulu 🌺@UVANeurology #SNO2025 #UVANeurooncology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Shout out to our amazing UVA neuro -oncology APP’s, Jim and Ellie for always going above and beyond for our patients! Happy APP week! @UVANeurology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Great to spend a Sunday afternoon with UVA neuro oncology team and families. Welcome to our new neuro onc fellows, Sami and Lexie! @UVANeurology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Congrats to Dr. Fadul and Dr. Grossman for organizing a successful first Mid Atlantic Neuro Oncology (MANO) symposium. And shout out to Dr. Peach for a great talk on the ECU experience of Gamma Tile in brain tumors @UVANeurology @ECUHealthNC

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Proud of the work of our brain tumor team! Obtaining this certification highlights our team’s unwavering dedication and commitment to delivering exceptional care for our patients with brain tumors in eastern North Carolina. @ECUHealthNC

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Contrary to previous data, our study, with a total of 736 patients with glioma per 2021 WHO classification, showed grade 4 IDH-mutant astrocytoma are significantly younger than IDH-wild type GBM.
https://t.co/Y8oMvJB5yV
#SNO2024 @UVANeurology @ECUHealthNC

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Temozolomide lives! Updated results of ECOG E3F05 presented by Dr. David Schiff showed survival benefit of RT+TMZ in grade 2 gliomas, with similar hazard ratio magnitude as RT+PCV in RTOG 9804 study. #SNO2024 @UVANeurology

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Always looking forward to our annual SNO dinner with the amazing UVA neuro oncology team. Can’t wait for the Hawaii reunion in 2025! #SNO2024 @UVANeurology @GSaraionc @lalanthica

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Late breaking abstract on the positive result of phase 3 STELLAR trial demonstrating significant improvement of OS and PFS with eflornithine and CCNU in grade 3 IDH mutant CDKN2 intact astrocytoma #SNO2024

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Exciting preclinical data on the utility of antiVEGF + tricyclic antidepressants + anti PD-L1 in GBM presented by distinguished professor Dr. Hanahan #SNO2024

[Joshua Budhu @JoshuaBudhu]

Plan on taking the UCNS board examination for neuro-oncology in 2025? Or want to review neuro-oncology and build community?

Then sign up for the free Neuro-Oncology Trainee Forum board review course! Monthly zoom sessions

https://t.co/yaJjGE3BmR

@AANmember @NeuroOnc

[JasminJoMD (find me in Bluesky) @JasminJoMD]

Pooled analysis showed no benefit of temozolomide in elderly patients with MGMT promoter unmethylated GBM. How do we define “truly unmethylated” GBM? Tune in to Neuro Oncology The Podcast to learn more from Dr. Monika Hegi.

https://t.co/3y25n0Xs33

[JasminJoMD (find me in Bluesky) @JasminJoMD]

An honor to talk about the key principles in brain tumor management along with these two awesome ladies! #AAN2024 #womeninneurology @ECUHealthNC @UVANeurology

[Nimish Mohile (he/him) @NimishMohile]

3 superstar women kicking off the Neuro-oncology education offerings at #AANAM ⁦with Core Principles of Brain Tumors: ⁦@JennieWTaylor⁩ ⁦@JasminJoMD⁩ and Heather Leeper.

[Maciej M Mrugala, MD, PhD, MPH, FAAN @MrugalaMaciej]

Fantastic team!